T. Craig Benson

Craig has been the CEO and Managing Director of Callaway Partners, LP since 2004. Callaway is engaged in various private investments in the areas of banking, specialty finance, oil and gas, and healthcare. Benson was CEO and President of Rules-Based Medicine Inc. (later MyriadRBM, Inc), a life sciences/diagnostic company, from January 2002 through December 2013, after directing its spin-off from Luminex Corporation (NASDAQ:LMNX). The business was acquired by Myriad Genetics (NASDAQ:MYGN) in 2011. During 2000-2004, he also served as Chairman of the Board for Equity Resource Partners, LLC, a private investment company. From 1987 through September 2000, Benson was employed by Service Corporation International (NYSE: SCI). During his tenure with SCI, he held various senior executive management positions, which included domestic and international merger and acquisition responsibilities, Vice-President of Marketing and Corporate Alliances, as well as President of SCI International Ltd., SCI’s International holding company with over $2 billion in global operations. From 1990 to 1994, Benson served as President of Investment Capital Corporation, the private equity arm of SCI, which held over $350 million in assets. From 1984 to 1987, he held management positions with Pulaski Investment Corporation, a bank holding company engaged in commercial and mortgage finance activities. Benson has served on the Board of Directors of various publicly held entities, including Florafax International, Tanknology Environmental Inc., Equity Corporation International and Pinnacle Global Group Inc. He received a BBA degree from Southern Methodist University in 1984. He currently serves as a founding member of the Board of Directors for Rock Bancshares Inc., the holding company for Heartland Bank, as well as for BioPhysical Corporation. In addition, Benson is the Chairman and Founding Director of Beyond Batten Disease Foundation and is a member of the Board of Directors for Batten Disease Support & Research Association.